SRNE News and Press, Sorrento Therapeutics Inc. From 09/22/20

Seventeen subjects with advanced cancer pain received epidural RTX (0.4 to 25 mcg). No dose limiting toxicities were reported, and a majority of patients reported meaningful pain reduction of 30% or more vs. baseline.Sorrento (SRNE) expects to immediately submit to the FDA a request to procee...

Seventeen subjects with advanced cancer pain received epidural RTX (0.4 to 25 mcg). No dose limiting toxicities were reported. A majority of patients reported meaningful pain reduction of 30% or more from baseline. Sorrento expects to submit to the FDA a request to proceed w...

Should You Look For Penny Stocks To Buy Or Is Amazon Better? Penny stocks are inherently volatile, that's a given. However, what we're seeing in the stock market today is that everything is volatile. It doesn't matter if you're looking at the S&P 500 ETF ( SPY ) or Amazon Inc. ( AMZN ), ...

Gainers:  Ebang International (NASDAQ: EBON ) +42% . More news on: Ebang International Holdings Inc., Cardiff Oncology, Inc., Herman Miller, Inc., Stocks on the move, , Read more ...

Should You Look For Penny Stocks To Buy Or Is Amazon Better? Penny stocks are inherently volatile, that’s a given. However, what we’re seeing in the stock market today is that everything is volatile. It doesn’t matter if you’re looking at the S&P ETF ( SPY ETF...

Shares of the mid-cap biopharma Sorrento Therapeutics (NASDAQ: SRNE) jumped by as much as 35% in pre-market trading Thursday morning. The stock is heating up today in response to the Food and Drug Administration clearing Sorrento's COVID-19 neutralizing antibody, COVI-Guard (STI-1499), for a...

Sorrento Therapeutics (NASDAQ: SRNE )   +30%  on FDA nod for early-stage COVID-19 antibody trial. More news on: Sorrento Therapeutics, Inc., Hepion Pharmaceuticals, Inc., Vaccinex, Inc., , Stocks on the move, Read more ...

Sorrento Therapeutics (NASDAQ: SRNE ) receives FDA clearance to with its Phase 1 clinical trial for COVI-GUARD (STI-1499) in hospitalized COVID-19 patients. More news on: Sorrento Therapeutics, Inc., Read more ...

Phase 1 clinical trial for STI-1499 (COVI-GUARD™) in hospitalized COVID-19 patients has received FDA notice that it may proceed with patient enrollment. The initial trial is expected to enroll rapidly and is expected to be followed by large trials targeting a potential Emergency Us...

Looking For Top Biotech Stocks To Watch This Week? Investors seeking out high growth in their investments will often turn to biotech stocks . The boom in the biotechnology industry in recent decades built on the increasing understanding we have on biology. For this reason, investors have been...